Insulet Corp., the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, entered into an agreement with Eli Lilly and Company. The agreement will have Insulet develop a new version of the medical device for which they are known, the OmniPod insulin pump, only this one will be specifically designed to deliver Humulin R U-500 insulin, (regular U-500 [Concentrated] insulin human injection, USP [rDNA origin]), a concentrated form of insulin used by people with highly insulin resistant type 2 diabetes. Insulet is partnering with Eli Lilly and Company on the clinical development program to evaluate the safety and efficacy of the combined delivery system.
As the incidence of severe insulin resistance continues to rise, more and more people with type 2 diabetes are requiring significantly higher doses of insulin in order to control their blood glucose. This new version of the OmniPod System would be the first insulin pump designed with specific feature modifications to deliver Humulin R U-500 insulin. Given the rapid increases in rates of obesity and corresponding increases in daily insulin requirements, the new delivery system, if approved, would represents a significant and growing opportunity for people with highly insulin resistant type 2 diabetes to potentially better manage their disease with such a product.
"We are pleased to develop the first insulin pump specifically for Humulin R U-500 insulin to bring the advantages of the OmniPod System to people with highly insulin resistant type 2 diabetes," states Duane DeSisto, president and CEO of Insulet. "The tubeless design of the OmniPod insulin pump provides freedom and ease of use for tens of thousands of people living with diabetes today."
About the OmniPod Insulin Management System
The OmniPod Insulin Management System is the world's first tubeless insulin pump. The OmniPod offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with freedom and ease. The tubing-free OmniPod insulin pump has just two easy-to-use parts: the discreet, waterproof Pod, which automatically inserts and can be worn on many parts of the body to hold and deliver insulin; and the Personal Diabetes Manager (PDM), a hand-held device that wirelessly programs the Pod, calculates suggested doses and has a built-in blood glucose meter. To read inspiring stories of people with diabetes living their lives to the fullest with OmniPod, visit our customer blog, Suite D: http://suited.myomnipod.com. For more information on the OmniPod insulin pump, please visit: http://www.myomnipod.com.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology